Dermatology Doctors in Lake Forest, IL Accepting Medicare

5 Dermatology doctors found. Showing 1 - 5

Dr. Mark Allan Berk, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 900 N Westmoreland Rd, Suite 222, Lake Forest, IL 60045 Phone: 847-234-6121    Fax: 847-482-0363

Dr. Katina C Venetos, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 800 N Westmoreland Rd, Suite 100c, Lake Forest, IL 60045 Phone: 847-234-1177    Fax: 847-234-1875

Dr. Amin Esfahani, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 800 N Westmoreland Rd Ste 201, Lake Forest, IL 60045 Phone: 847-535-7664    Fax: 312-694-1155

Dr. Carla Sanchez Palacios, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 900 N Westmoreland Rd, Suite 222, Lake Forest, IL 60045 Phone: 847-234-6121    Fax: 847-482-0363

Dr. Julia M Marshall, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 800 N Westmoreland, Ste 100b, Lake Forest, IL 60045 Phone: 847-295-7700    Fax: 847-295-1910

News Archive

Chemists adapt natural strategies to improve performance of DNA detectors

Over their 3.8 billion years of evolution, living organisms have developed countless strategies for monitoring their surroundings. Chemists at UC Santa Barbara and University of Rome Tor Vergata have adapted some of these strategies to improve the performance of DNA detectors. Their findings may aid efforts to build better medical diagnostics, such as improved HIV or cancer tests.

Knopp and NIAID collaborate to investigate eosinophil-lowering effects of dexpramipexole

Knopp Biosciences LLC today announced a second collaboration with the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to investigate the eosinophil-lowering effects of the investigational drug dexpramipexole.

Artisan Pharma enrolls 750 patients in Phase 2b study of ART-123 in sepsis patients with DIC

Artisan Pharma, Inc., a private biopharmaceutical company dedicated to bringing best-in-class critical care therapeutics to patients, today announced the completion of patient enrollment in its Phase 2b study of ART-123 (Recomodulin® - recombinant human thrombomodulin) in sepsis patients with disseminated intravascular coagulation (DIC). The clinical trial was a randomized, double-blind, placebo-controlled Phase 2b study to assess the safety and efficacy of ART-123 in patients with sepsis and DIC.

Insomnia patients commonly underestimate their actual sleep behavior

People with sleep disorders commonly have a misperception about their actual sleep behavior. A research group led by Karin Trimmel and Stefan Seidel from MedUni Vienna's Department of Neurology (Outpatient Clinic for Sleep Disorders and Sleep-Related Disorders) analyzed polysomnography results to identify the types of sleep disorder that are associated with a discrepancy between self-reported and objective sleep parameters and whether there are any factors that influence this.

Drinking unprocessed cow's milk prevents allergies, shows study

Numerous studies have shown that growing up on a farm and drinking natural, unprocessed cow's milk in early childhood protects against the development of immunoglobulins E (IgE), which are responsible for allergy symptoms.

Read more Medical News

› Verified 1 days ago